Atlas Trials

A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Clinical trial NCT03603132 · COMPLETED

Trial details

NCT number
NCT03603132
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2018-07-14
Primary completion
2018-08-17
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.